Christos Vaklavas   (MD )

Dr. Vaklavas received his MD degree from the Aristotle University of Thessaloniki in Greece. He completed his residency in Internal Medicine at the University of Texas at Houston. After a fellowship at the Phase I program at MD Anderson, he went on to complete his fellowship in Hematology and Medical Oncology at the University of Alabama at Birmingham where he was retained as faculty. He joined Huntsman Cancer Institute in summer 2019. He is a translational scientist bringing all the basic science done in the Institute closer to clinical applications. As the Physician Leader in Breast Cancer at the Huntsman Cancer Institute, he is responsible for the clinical research portfolio in breast cancer and leads many clinical trials that intend to bring the basic science conducted at Huntsman Cancer Institute closer to clinical applications. He is the recipient of multiple awards including a Young Investigator Award from ASCO, a Career Catalyst Award in Basic and Translational Research from Susan G Komen, and the very first recipient of the Daniel D. Von Hoff Innovative Protocol Award from the ASCO and AACR.

Disclosure

Yes, I have had a financial relationship with an ineligible company within the past 24 months. Financial relationships: Attribution: Spouse or Partner Type of financial relationship: Employment Ineligible company: Flatiron Attribution: Self Type of financial relationship: Professional Services Ineligible company: Guidepoint Topic: Consultation Attribution: Self Type of financial relationship: Professional Services Ineligible company: Novartis Topic: Consultation Relationship end date: 06/05/2023 Attribution: Self Type of financial relationship: Professional Services Ineligible company: SeaGen Topic: Consultation Relationship end date: 12/05/2023 Attribution: Self Type of financial relationship: Professional Services Ineligible company: Gilead Topic: Participation in non-CME activity Relationship end date: 01/15/2025 Attribution: Self Type of financial relationship: Professional Services Ineligible company: AstraZeneca Topic: Participation in non-CME activity Relationship end date: 03/15/2024 Attribution: Self Type of financial relationship: Professional Services Ineligible company: AstraZeneca Topic: Consultation Relationship end date: 12/10/2024 Attribution: Other Type of financial relationship: Financial Support Ineligible company: Pfizer Topic: Research paid to my Institution Attribution: Other Type of financial relationship: Financial Support Ineligible company: SeaGen Topic: Research paid to my Institution Attribution: Other Type of financial relationship: Financial Support Ineligible company: H3 Biomedicine Topic: Research paid to my Institution Attribution: Other Type of financial relationship: Financial Support Ineligible company: AstraZeneca Topic: Research paid to my Institution Attribution: Other Type of financial relationship: Financial Support Ineligible company: CytomX Topic: Research paid to my Institution